Revision as of 15:42, 2 August 2012 edit160.45.25.162 (talk) →Missing BSL-3 Site← Previous edit | Revision as of 12:59, 17 August 2012 edit undoSperril (talk | contribs)Extended confirmed users2,319 edits →Missing BSL-3 SiteNext edit → | ||
Line 32: | Line 32: | ||
:Do we actually need the BSL-3 sites at all? The article states that "a total of 1356 CDC/USDA registered BSL-3 facilities were identified throughout the United States", which is clearly too much for a Misplaced Pages list. Also in Europe there are probably thousands of them. The list will be always incomplete. Should we maybe focus on BSL-4 labs instead? There are only something around 30 of these labs worldwide, which would be far easier to deal with. ] (]) 15:41, 2 August 2012 (UTC) | :Do we actually need the BSL-3 sites at all? The article states that "a total of 1356 CDC/USDA registered BSL-3 facilities were identified throughout the United States", which is clearly too much for a Misplaced Pages list. Also in Europe there are probably thousands of them. The list will be always incomplete. Should we maybe focus on BSL-4 labs instead? There are only something around 30 of these labs worldwide, which would be far easier to deal with. ] (]) 15:41, 2 August 2012 (UTC) | ||
::I agree. BSL-4 facilities are significant because of their rarity. A BSL-3 facility is pretty common in comparison. ] (]) 12:59, 17 August 2012 (UTC) | |||
== Genetically modified organisms are BSL-2? == | == Genetically modified organisms are BSL-2? == |
Revision as of 12:59, 17 August 2012
This is the talk page for discussing improvements to the Biosafety level article. This is not a forum for general discussion of the article's subject. |
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1Auto-archiving period: 14 days |
Medicine C‑class Low‑importance | ||||||||||
|
Laboratory personnel have specific training in handling pathogenic and potentially lethal agents, and are supervised by competent scientists who are experienced in working with these agents. This is considered a neutral or warm zone.
This doesn't make much sense. What's considered a neutral to warm zone? The staff, the workplace, the safety level, the agent? And there is no explanation of what neutral to warm is. If it's referencing the safety level, level three is not going to be neutral, that'd make level 1 minus neutral, somehow. — Preceding unsigned comment added by 109.149.157.19 (talk) 16:26, 28 December 2011 (UTC)
Noguchi Memorial Institute for Medical Research
Revision 456170207 by 197.255.96.5 (talk) added "Noguchi Memorial Institute for Medical Research" (NMIMR) to the External links section, but without any external link, citation, or indication of biosafety levels. I'm moving it to this talk page until the BSL can be confirmed.
I conducted a research project at the Noguchi Institute, and I can attest that they do operate both BSL-2 and BSL-3 facilities. I can provide photographic evidence if that would help. NicholasBayless (talk) 15:04, 11 May 2012 (UTC)
The institute is in Ghana, is named after Hideyo Noguchi, and apparently has a BSL-2 or BSL-3 laboratory, or both. Some references:
- Addo, Phyllis; Quartey, Maxwell; Abbas, Mona; Adu-Addai, Benjamin; Owusu, Enid; Okang, Ishmael; Dodoo, Alfred; De Souza, Dziedom; Ankrah, Nii-Ayi; Ofori-Adjei, David (2008), "In-Vitro Susceptibility of Mycobacterium Ulcerans to Herbal Preparations", The Internet Journal of Tropical Medicine, 4 (2), ISSN 1540-2681, retrieved 2011-11-20. Mentions a level 2 biosafety laboratory at NMIMR.
- "Department of Virology". Noguchi Memorial Institute for Medical Research. University of Ghana. Retrieved 2011-11-20.
Good laboratory practices are strictly followed and special training provided for staffs who work in a biosafety level 3 (BSL 3) environment with related pathogens.
- Josephine NKETSIA-TABIRI, Ph.D (2003). Report on “The Survey on Programmes for Safe Use of Biotechnology/Biosafety And Existing Status of Biotechnology And Living Modified Organisms (LMOs) in Ghana” (PDF). National Review Workshop on “Surveys on Biotechnology, Biosafety Programmes and Related Legislation in Ghana”. UNEP-GEF, NBC, and BNARI. p. 44. ISBN 9988-8274-5-8. Retrieved 2011-11-20.
It is note-worthy that the NMIMR of UG has a level 3 pathogen-free laboratory.
85.23.32.64 (talk) 14:36, 20 November 2011 (UTC)
Missing BSL-3 Site
The Biosecurity Research Institute at Kansas State University in Manhattan Kansas has a BSL-3, ABSL-3 (animal BSL-3), BSL-3E (Enhanced BSL-3) and BSL-3Ag facility. It is located next to where the new BSL-4 facility is being built. It is mentioned in the article on the new facility but not listed as having its own BSL-3. This information was gleaned from a job posting on their website. So I assume it is reasonably accurate. DJBostrom (talk) 18:42, 3 December 2011 (UTC)
- Do we actually need the BSL-3 sites at all? The article states that "a total of 1356 CDC/USDA registered BSL-3 facilities were identified throughout the United States", which is clearly too much for a Misplaced Pages list. Also in Europe there are probably thousands of them. The list will be always incomplete. Should we maybe focus on BSL-4 labs instead? There are only something around 30 of these labs worldwide, which would be far easier to deal with. 160.45.25.162 (talk) 15:41, 2 August 2012 (UTC)
- I agree. BSL-4 facilities are significant because of their rarity. A BSL-3 facility is pretty common in comparison. Sperril (talk) 12:59, 17 August 2012 (UTC)
Genetically modified organisms are BSL-2?
Does anyone have a reference for the claim that "Genetically modified organisms have also been classified as level 2 organisms"? Seems like most iGEM projects are being done in BSL-1 labs. Patrikd (talk) 08:24, 9 December 2011 (UTC)
I deleted this statement, since it was clearly incorrect. According to the CDC, the NIH Guidelines are the key reference in assessing risk and establishing an appropriate biosafety level for work involving recombinant DNA molecules: http://oba.od.nih.gov/oba/rac/Guidelines/NIH_Guidelines.htm Patrikd (talk) 21:56, 9 December 2011 (UTC)
Categories: